At the European Association for the Study of Diabetes conference in September 2024, researchers reported that in early trials, amycretin led to a 10.4% loss of body weight in people who were overweight or obese when taken at its lowest dose for 12 weeks
Sermorelin is most commonly given by subcutaneous injection
Burgold T, Spreafico F, De Santa F, Totaro MG, Prosperini E, Natoli G et al
Losing significant weight can result in a depleted facial volume (sometimes called Ozempic face) and loose skin around the abdomen, arms, and thighs
Consultation from AED 500
Patients are encouraged to communicate with their providers and pharmacists to understand their options and ensure uninterrupted treatment.